Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Occidental Petroleum Corporation — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.35 (market cap $29.60B), while Occidental Petroleum Corporation trades at $58.74 (market cap $55.89B). The key difference: Occidental Petroleum Corporation is the larger of the two by market cap, and Occidental Petroleum Corporation pays a 2% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | OXY | |
|---|---|---|
Market Cap | $29.60B | $55.89B |
Sector | Health | Energy |
52-Week High | $491.22 | $66.24 |
52-Week Low | $205.48 | $38.92 |
Enterprise Value | $27.56B | $74.65B |
Dividend Yield | — | 2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Occidental Petroleum (OXY) trades at $58.65, up 4.9% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $2.40, exceeding expectations, and is focusing on debt reduction while targeting over $4 billion in annual sustainable cash flow by 2030. Valuation ratios remain reasonable with a P/E of 16.49 and EV/EBITDA of 5.26.
The outlook is positive, driven by operational outperformance and higher oil prices, but remains sensitive to commodity volatility. Analyst consensus is a Buy with a $69.33 price target, though execution risks and oil price dependence are key considerations for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
